As noted below, the Nov. 18 webcast will be available through Dec. 18th.
Avigen Presenting at NYSSA 7th Annual Healthcare Conference Today
Tuesday November 18, 8:02 am ET
ALAMEDA, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Avigen, Inc., (Nasdaq: AVGN - News), a leader in the development of gene-based drugs for serious chronic diseases, announced that its president and CEO, John Monahan, Ph.D., will make a presentation at the New York Society of Securities Analysts 7th Annual Healthcare Conference in New York City at 1:30 p.m. eastern time today, Tuesday, November 18, 2003.
ADVERTISEMENT
Dr. Monahan will provide an overview of the company's proprietary gene delivery technology and recent events in the company's primary product development programs in hemophilia and Parkinson's disease, including the filing of an IND for AV201, Avigen's ground breaking approach to the treatment of advanced Parkinson's disease.
The presentation will be webcast live at shareholder.com and through Avigen's web site, www.avigen.com. An archived version of the presentation will be available through December 18, 2003. |
